The subject matter of the present invention is a synthetic polysulfated oligosaccharide having 1 to 4 monosaccharaide units, salts thereof, or complexes thereof, at a concentration greater than or equal to 70 mg/mL, for use thereof for activating angiogenesis, in particular for activating angiogenesis during wound healing.